Find your path to John
180 people in our graph share verified history with John — schools, employers, funds. One of them is your warm intro.
Sarah AlfaddaunlockedJohn: together at TechGC (2022–2026)
×4John: together at TechGC
×5John: together at University of California, College of the Law, San Francisco (formerly UC Hastings)
×2John: together at University of North Carolina Wilmington
Executive at Autobahn Therapeutics, Inc.
Intro paths
→
In turn, John can intro founders to Autobahn Therapeutics, Inc.'s investors below.
Autobahn Therapeutics, Inc.'s investors · 6
ARCH Venture PartnersChicago · $50K – $250M checks · since 2024Canaan PartnersStamford · $500K – $20M checks · since 2024Monograph Capital PartnersLondon · since 2024Newpath PartnersBoston · $50K – $10M checks · since 2024Pfizer Venture Investments$5M – $20M checks · since 2024Samsara BioCapitalPalo Alto · since 2024
Co-founders at Autobahn Therapeutics, Inc.
KF

Kevin FinneyChairman, President and CEO
Experience
- Autobahn Therapeutics, Inc.Chief Financial & Legal Officercurrent2025 — present
- Autobahn Therapeutics, Inc.General Counsel & SVP, Administration2018 — 2025San Diego, CA
- John Borkholder ConsultingBiotechnology Legal & Operations Consultantcurrent2018 — presentSan Francisco Bay Area
- TechGCCharter Membercurrent2022 — present
- Rennovia Inc.VP & General Counsel2014 — 2018San Francisco Bay Area
- Maxygen, Inc.General Counsel & Secretary2005 — 2014
- Orrick, Herrington & Sutcliffe LLPAssociate2000 — 2005
- Giancarlo & Gnazzo, P.C.Associate1998 — 2000
Skills & more
BiotechnologyCorporate LawMergers & AcquisitionsCorporate GovernanceFundraising & FinancingSecuritiesBoard GovernanceSEC filingsIntellectual PropertyLicensingStrategic PlanningCompensation Strategies
+12 more
Management Of Outside CounselBusiness DevelopmentDrafting AgreementsBudget ProcessStakeholder EngagementTeam Building & LeadershipOperational ExcellenceMission & Culture DevelopmentCross-Functional Leadership (Legal, Finance, HR, IT, Facilities)Founding Team ExperienceExecutive LeadershipCross-Border LicensingFrom John's professional profile.
Frequently asked questions
- Who is John Borkholder?
- Executive Officer at Autobahn Therapeutics, Inc.
- Where does John Borkholder work?
- John Borkholder is Executive at Autobahn Therapeutics, Inc..
- Where did John Borkholder go to school?
- John Borkholder studied at University of California, College of the Law, San Francisco (formerly UC Hastings) (JD); University of North Carolina Wilmington (BA, Philosophy).
Same school
Also attended University of California, College of the Law, San Francisco (formerly UC Hastings)52
Greg RudinBoard Partner at Menlo VenturesStephan EberleGeneral Counsel & Head of Limited Partner Relations at Scale Venture PartnersMyles GutenkunstInvestor at Index VenturesBen HinshawDeputy General Counsel at ParadigmJennifer KercherGeneral Counsel at Westlake Village BioPartnersEmily ChanExecutive Assistant at BA Capital
+ 46 more
Also attended University of North Carolina Wilmington35
Dianna D'AmorePrincipal - Investor Relations at Marlin Equity PartnersJenn SummeGeneral Partner at Primordial VenturesSteve LapinController at Alpha EdisonMike PrivetteVenture Partner, Cybersecurity at Bright Pixel CapitalJamie RiggsCo-Founder and General Partner at DrivenAngela StanleyPartner at Akkadian Ventures
+ 29 more
Shared employers
Also worked at Autobahn Therapeutics, Inc.2
Also worked at TechGC81
Sarah AlfaddaAssociate General Counsel at Sapphire VenturesAbigail JohnsonPartner, Chief Operating Officer at Sapphire VenturesMichael OdaiCOO & General Counsel at Mosaic VenturesJulia Gonzalez SandersPartner and General Counsel at Crosslink CapitalLeslie StolperInvestor at IVP (Institutional Venture Partners)Heather StevensonGeneral Counsel at Red Cell Incubation
+ 75 more
Also worked at Rennovia Inc.2
Also worked at Maxygen, Inc.10
Jamie BacherEntrepreneur-In-Residence at The Innovation SpaceRuchita SinhaGeneral Partner at AV8 VenturesJosh SilvermanInvestor at Baruch Future VenturesGjalt HuismanInvestor at Baruch Future VenturesKeith LendenVenture Partner at ARCH Venture PartnersJan Møller MikkelsenPresident at Ascendis Pharma A/S
+ 4 more





























